-
Abbott Laboratories v. Grifols Diagnostic Solutions Inc. et al DC
- 1:19-cv-06587
- N.D. Ill.
- Judge: Sara Lee Ellis
- Filed: 10/03/2019
- Latest Docket Entry: 04/12/2024
- PACER
- Docket updated daily
1
Plaintiff
3
Defendants
0
Accused
Products
1
Patent-in-Suit
1,666
Days in
Litigation
-
Abbott Laboratories v. Grifols Diagnostic Solutions Inc. et al DC
- 1:19-cv-06587
- N.D. Ill.
- Judge: Sara Lee Ellis
- Filed: 10/03/2019
- Latest Docket Entry: 04/12/2024
- PACER
- Docket updated daily
Cause of Action
Declaratory Judgment
Patent Invalidity
Market Sector
Medical
Assigned Judge
- Patent Information
-
Validity & Enforceability
| Claim # | Claim Text | Outcome |
|---|---|---|
| 1 |
A method for replicating DNA specific for HIV, which comprises: (a) providing a DNA construct comprising an origin of replication recognized by a unicellular microorganism and a DNA sequence comprising at least a 20 bp sequence of a human
view more
|
Invalid
Entry 196 |
| 3 |
The method according to claim 1 wherein the DNA construct contains a env sequence of HIV.
|
Invalid
Entry 196 |
| 7 |
The method of claim 1, 2 or 3 wherein the unicellular microorganism is a bacterial cell.
|
Invalid
Entry 196 |
| 9 |
The method of claim 1, 2, or 3 wherein the HIV sequence is an env sequence of <figref idref="DRAWINGS">FIG. 4</figref>.
|
Valid
Entry 196 |
| 10 |
The method of claim 1, 2, or 3 wherein the HIV sequence is at least 45 base pairs long.
|
Invalid
Entry 196 |
| 17 |
A method for replicating DNA specific for HIV, which comprises: (a) providing a DNA construct comprising an origin of replication recognized by a unicellular microorganism and a DNA sequence comprising at least a 20 basepair sequence of a human
view more
|
Valid
Entry 196 |
-
Infringement
Grifols Diagnostic Solutions Inc.
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| NA | US 7,205,101 B1 |
9, 17
|
No infringement
Entry 196
|
Grifols Worldwide Operations Limited
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| NA | US 7,205,101 B1 |
9, 17
|
No infringement
Entry 196
|
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| NA | US 7,205,101 B1 |
9, 17
|
No infringement
Entry 196
|
